Lupin's Diazepam Injection, USP receives US approval
Auxilium Health changes name to Aeris Biosciences
Saol Therapeutics' SL1009 (DCA) resubmission accepted by FDA
Lantern Pharma advances EMA-cleared Phase 1b/2 bladder cancer trial for LP-184
AcuCort secures renewed FDA fee waiver ahead of planned NDA submission
Yarrow Bioscience completes VYNE merger and begins Phase 2 trial of YB-101
Asymchem's DH2 site completes first FDA inspection for continuous manufacturing of API